Hims & Hers Health Inc [HIMS] stock is trading at $35.83, down -1.19%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The HIMS shares have lost -8.18% over the last week, with a monthly amount drifted -27.41%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Needham downgraded its rating to Hold on June 23, 2025. On June 04, 2025, Needham reiterated its Buy rating and revised its price target to $65 on the stock. TD Cowen downgraded its rating to a Hold but stick to its price target of $30 on April 29, 2025. Morgan Stanley downgraded its rating to a Equal-Weight and raised its price target to $60 on February 18, 2025. Citigroup downgraded its rating to Sell for this stock on January 10, 2025, and upped its price target to $25. In a note dated January 07, 2025, BTIG Research initiated a Buy rating and provided a target price of $35 on this stock.
Hims & Hers Health Inc [HIMS] stock has fluctuated between $20.02 and $72.98 over the past year. Currently, Wall Street analysts expect the stock to reach $46.5 within the next 12 months. Hims & Hers Health Inc [NYSE: HIMS] shares were valued at $35.83 at the most recent close of the market. An investor can expect a potential return of 29.78% based on the average HIMS price forecast.
Analyzing the HIMS fundamentals
Hims & Hers Health Inc [NYSE:HIMS] reported sales of 2.21B for the trailing twelve months, which represents a growth of 49.16%. Gross Profit Margin for this corporation currently stands at 0.75% with Operating Profit Margin at 0.05%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.06%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.25 and Total Capital is 0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.92.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 34.64 points at the first support level, and at 33.45 for the second support level. However, for the 1st resistance point, the stock is sitting at 36.81, and for the 2nd resistance point, it is at 37.79.
Ratios To Look Out For
For context, Hims & Hers Health Inc’s Current Ratio is 1.88. As well, the Quick Ratio is 1.64, while the Cash Ratio is 0.77. Considering the valuation of this stock, the price to sales ratio is 3.69, the price to book ratio is 14.03 and price to earnings (TTM) ratio is 66.24.
Transactions by insiders
Recent insider trading involved Okupe Oluyemi, Chief Financial Officer, that happened on Nov 17 ’25 when 23187.0 shares were sold. Chief Legal Officer, Boughton Soleil completed a deal on Nov 10 ’25 to sell 2637.0 shares. Meanwhile, Officer Boughton Soleil bought 2637.0 shares on Nov 10 ’25.
